23andMe just laid off 100 employees as the DNA-testing ‘fad’ ends

23andMe is laying off 100 amid a slowdown in the consumer genetics market, CNBC first reported Thursday. The layoffs hit departments across the organization in an effort to scale back on work that isn’t core to the consumer testing and therapeutics businesses, a company spokesman told Business Insider.It’s happening at a time when sales of genetics…

23andMe just laid off 100 employees as the DNA-testing ‘fad’ ends

23andMe is laying off 100 amid a slowdown in the consumer genetics market, CNBC first reported Thursday. The layoffs hit departments across the organization in an effort to scale back on work that isn’t core to the consumer testing and therapeutics businesses, a company spokesman told Business Insider.It’s happening at a time when sales of genetics tests have disappointed, with Wall Street signalling that the consumer genetics “fad” is over. Click here for more BI Prime stories.DNA-testing giant 23andMe is laying off about 14% of its staff, the latest sign of a slump in the business.About 100 employees have been let go in departments across the organization in an effort to scale back on work that isn’t core to the consumer testing and therapeutics businesses that 23andMe operates, a spokesman told Business Insider. The therapeutics team was not impacted by the la
Read More From Publisher